Page last updated: 2024-10-23

bumetanide and Hyaline Membrane Disease

bumetanide has been researched along with Hyaline Membrane Disease in 1 studies

Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).

Research Excerpts

ExcerptRelevanceReference
"Furosemide, because of its actions on the ubiquitous Na(+) -K(+) -2Cl(-) isoform cotransporter and its promotion of prostanoid production and release, also has non-diuretic effects on vascular smooth muscle, airways, the ductus arteriosus and theoretically the gastrointestinal tract."2.48Unexpected extra-renal effects of loop diuretics in the preterm neonate. ( Cotton, R; Reese, J; Suarez, S, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cotton, R1
Suarez, S1
Reese, J1

Reviews

1 review available for bumetanide and Hyaline Membrane Disease

ArticleYear
Unexpected extra-renal effects of loop diuretics in the preterm neonate.
    Acta paediatrica (Oslo, Norway : 1992), 2012, Volume: 101, Issue:8

    Topics: Biomarkers; Bronchopulmonary Dysplasia; Bumetanide; Central Nervous System; Diuretics; Ductus Arteri

2012